Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. NASDAQ OMX GlobeNewswire Message Board

B. Braun Launches Easypump® Home Infusion Therapy

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 301275
(Total Views: 34)
Posted On: 04/05/2017 10:00:24 AM
Avatar
Posted By: News Desk 2018
B. Braun Launches Easypump® Home Infusion Therapy App For Healthcare Professionals and Patients

BETHLEHEM, Pa., April 05, 2017 (GLOBE NEWSWIRE) -- Clinicians and patients using B. Braun Medical Inc.’s Easypump ® ST/LT Elastomeric Infusion Pump System have a new tool to help them safely administer medication. B. Braun is introducing an innovative app that offers educational content to clinicians and patients on the safe use and features of the Easypump for short- and long-term home infusion therapy.

An aging population, a rise in chronic conditions, and a focus on reducing healthcare costs are contributing to a forecasted increase in home infusion in the coming years. For customers and partners who provide home infusion, B. Braun is committed to sharing knowledge through tools like the Easypump app.

“B. Braun designed this app as a resource to help infusion therapy nurses teach patients how to safely administer the Easypump in the comfort of their own homes,” said Mike Connelly, Director of Marketing, Elastomeric Infusion Systems at B. Braun. “Home infusion is a cost-effective and convenient alternative for many patients who otherwise would have a complicated electronic pump to manage or a need to travel to an inpatient or outpatient facility.”

Infusion therapy allows medication to be delivered from a reservoir, such as the Easypump ST/LT, through a venous access device directly into the bloodstream. For certain conditions, receiving medication directly into the bloodstream is more effective than taking medication orally. The most common type of medication administered by infusion therapy is antibiotics.

The Easypump app, for Apple and Android devices, offers simple menus and navigation, giving infusion therapy nurses a table-top tool for teaching patients how to properly use and manage the small, light-weight pump. The app includes facts about the infusion therapy process and easy-to-understand graphics and videos that explain the Easypump ST (for infusions ranging from 30 minutes to 4 hours) and Easypump LT (which can infuse for one to three days). The app allows infusion nurses to reinforce the safe and proper use of Easypump.

About Easypump ST/LT B. Braun’s Easypump ST/LT is a disposable, easily transportable pump with elastic properties that allow it to stretch when filled and contract as it empties. The elastomeric membrane uses positive pressure to infuse a prescribed amount of medication or solution in a steady, controlled flow. Easypump ST/LT features a patented “Sliding Core” technology designed for consistent, concentric balloon contraction.

The pump’s clear silicone elastomeric material allows clinicians to inspect for particulates after filling. It is not made with natural rubber latex, minimizing concerns about allergies and discoloration, and its single-use system is designed for clean and easy handling.

About B. Braun B. Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the health care industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pa., and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap ® and CAPS ® .

Globally, the B. Braun Group of Companies employs more than 58,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with customers, partners and clinicians to address the critical issues of improving care and lowering costs. To learn more about B. Braun Medical, visit www.BBraunUSA.com .

Contact: Jason Ford B. Braun Medical Inc. 610.997.4722 jason.ford@bbraun.com



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us